20Slash20 Inc., the innovator behind The Eye Drink, is set to be highlighted in coverage of the upcoming Disruptive Growth & Life Sciences Conference hosted by Moody Capital Solutions. The company’s participation underscores a growing trend in functional beverages aimed at addressing modern health challenges, particularly those stemming from prolonged digital screen use.
The Eye Drink is touted as the world’s first ready-to-drink functional beverage specifically formulated to minimize ocular issues in today’s screen-heavy world. With millions of people spending long hours daily staring at computer and smartphone screens, the product targets screen-induced dry eyes and potential macular damage. Its formulation is based on science-backed nutrients from the AREDS 2 studies, along with vegan-friendly, triglyceride-formed Omega-3 fatty acids, which are known to support visual performance and ocular comfort.
The company is leveraging multiple distribution channels, including direct-to-consumer sales, professional medical affiliate networks, and natural product retail stores. This multi-pronged approach aims to modernize preventive eyecare by turning clinical science into a simple, delicious, and enjoyable daily habit. For more information about The Eye Drink, visit theeyedrink.com.
The Disruptive Growth & Life Sciences Conference, organized by Moody Capital Solutions, is designed to showcase innovative companies across various sectors. Registration details are available at moodycapital.com/conference. IBN, a multifaceted financial news and publishing company, will provide comprehensive coverage of the event, including summaries of participating companies, through its custom-built portal. IBN’s coverage can be accessed at ibn.fm/MoodyCapital2026Conference.
Moody Capital Solutions, with over 40 years of experience, is an independent, full-service investment bank known for its expertise in capital raising, M&A, and advisory services, and is recognized as a market leader in rights offerings. The firm is a member of FINRA and SIPC. More details are available at moodycapital.com.
IBN has been providing real-time coverage for numerous global events and conferences for over a decade. Its syndication partners extend digital coverage to financial websites and platforms visited by millions of investors daily, maximizing visibility for event participants. For more information about IBN’s services, visit ibn.ai.
This conference appearance is significant for 20Slash20 as it brings attention to the intersection of functional beverages and eye health, a niche that is gaining relevance due to the pervasive use of digital devices. By aligning with clinical research and offering a convenient format, The Eye Drink could set a precedent for future products aimed at mitigating the adverse effects of modern lifestyles.
